126 related articles for article (PubMed ID: 23683426)
1. [The effect of the adverse events with thiopurine S-methyltransferase gene mutation on outcome of childhood acute lymphoblastic leukemia].
Cao L; Zhang ZX; Chai YH; Hu SY; Wang Y; Zhao WL; He HL; Lu J
Zhonghua Xue Ye Xue Za Zhi; 2013 Mar; 34(3):247-52. PubMed ID: 23683426
[TBL] [Abstract][Full Text] [Related]
2. Thiopurine S-methyltransferase phenotype-genotype correlation in children with acute lymphoblastic leukemia.
Chrzanowska M; Kuehn M; Januszkiewicz-Lewandowska D; Kurzawski M; Droździk M
Acta Pol Pharm; 2012; 69(3):405-10. PubMed ID: 22594254
[TBL] [Abstract][Full Text] [Related]
3. Analysis of thiopurine S-methyltransferase polymorphism in the population of Serbia and Montenegro and mercaptopurine therapy tolerance in childhood acute lymphoblastic leukemia.
Dokmanovic L; Urosevic J; Janic D; Jovanovic N; Petrucev B; Tosic N; Pavlovic S
Ther Drug Monit; 2006 Dec; 28(6):800-6. PubMed ID: 17164697
[TBL] [Abstract][Full Text] [Related]
4. TPMT gene expression is increased during maintenance therapy in childhood acute lymphoblastic leukemia patients in a TPMT gene promoter variable number of tandem repeat-dependent manner.
Kotur N; Dokmanovic L; Janic D; Stankovic B; Krstovski N; Tosic N; Katsila T; Patrinos GP; Zukic B; Pavlovic S
Pharmacogenomics; 2015; 16(15):1701-12. PubMed ID: 26411491
[TBL] [Abstract][Full Text] [Related]
5. Thiopurine methyltransferase (TPMT) genotype and early treatment response to mercaptopurine in childhood acute lymphoblastic leukemia.
Stanulla M; Schaeffeler E; Flohr T; Cario G; Schrauder A; Zimmermann M; Welte K; Ludwig WD; Bartram CR; Zanger UM; Eichelbaum M; Schrappe M; Schwab M
JAMA; 2005 Mar; 293(12):1485-9. PubMed ID: 15784872
[TBL] [Abstract][Full Text] [Related]
6. [Correlations between 6-mercaptopurine treatment-related adverse reactions in children with acute lymphoblastic leukemia and polymorphisms of thiopurine methyltransferase gene].
Xie C; Yue LJ; Ding H; Ren YF; Yang CL; Zheng MM
Zhongguo Dang Dai Er Ke Za Zhi; 2014 May; 16(5):499-503. PubMed ID: 24857000
[TBL] [Abstract][Full Text] [Related]
7. Thiopurine dose intensity and treatment outcome in childhood lymphoblastic leukaemia: the influence of thiopurine methyltransferase pharmacogenetics.
Lennard L; Cartwright CS; Wade R; Vora A
Br J Haematol; 2015 Apr; 169(2):228-40. PubMed ID: 25441457
[TBL] [Abstract][Full Text] [Related]
8. [Importance of genotyping of thiopurine S-methyltransferase in children with acute lymphoblastic leukaemia during maintenance therapy].
Dokmanović L; Janić D; Krstovski N; Zukić B; Tosić N; Pavlović S
Srp Arh Celok Lek; 2008; 136(11-12):609-16. PubMed ID: 19177822
[TBL] [Abstract][Full Text] [Related]
9. Thiopurine S-methyltransferase (TPMT) polymorphisms in children with acute lymphoblastic leukemia, and the need for reduction or cessation of 6-mercaptopurine doses during maintenance therapy: the Polish multicenter analysis.
Peregud-Pogorzelski J; Tetera-Rudnicka E; Kurzawski M; Brodkiewicz A; Adrianowska N; Mlynarski W; Januszkiewicz D; Drozdzik M
Pediatr Blood Cancer; 2011 Oct; 57(4):578-82. PubMed ID: 21319286
[TBL] [Abstract][Full Text] [Related]
10. Application of SNaPshot for analysis of thiopurine methyltransferase gene polymorphism.
Kapoor G; Maitra A; ; Brahmachari V
Indian J Med Res; 2009 May; 129(5):500-5. PubMed ID: 19675376
[TBL] [Abstract][Full Text] [Related]
11. Thiopurine methyltransferase polymorphic tandem repeat: genotype-phenotype correlation analysis.
Yan L; Zhang S; Eiff B; Szumlanski CL; Powers M; O'Brien JF; Weinshilboum RM
Clin Pharmacol Ther; 2000 Aug; 68(2):210-9. PubMed ID: 10976552
[TBL] [Abstract][Full Text] [Related]
12. Thiopurine S-methyltransferase (TPMT) gene polymorphism in Brazilian children with acute lymphoblastic leukemia: association with clinical and laboratory data.
Silva MR; de Oliveira BM; Viana MB; Murao M; Romanha AJ
Ther Drug Monit; 2008 Dec; 30(6):700-4. PubMed ID: 19057372
[TBL] [Abstract][Full Text] [Related]
13. Thiopurine methyltransferase polymorphisms and mercaptopurine tolerance in Turkish children with acute lymphoblastic leukemia.
Albayrak M; Konyssova U; Kaya Z; Gursel T; Guntekin S; Percin EF; Kocak U
Cancer Chemother Pharmacol; 2011 Nov; 68(5):1155-9. PubMed ID: 21400026
[TBL] [Abstract][Full Text] [Related]
14. Thiopurine methyltransferase in acute lymphoblastic leukaemia: biochemical and molecular biological aspects.
Brouwer C; De Abreu RA; Keizer-Garritsen JJ; Lambooy LH; Ament K; ter Riet PG; van Wering ER; Trijbels FJ; Veerman AJ; Hoogerbrugge PM; Bökkerink JP
Eur J Cancer; 2005 Mar; 41(4):613-23. PubMed ID: 15737567
[TBL] [Abstract][Full Text] [Related]
15. Thiopurine S-methyltransferase gene polymorphism and 6-mercaptopurine dose intensity in Indian children with acute lymphoblastic leukemia.
Kapoor G; Sinha R; Naithani R; Chandgothia M
Leuk Res; 2010 Aug; 34(8):1023-6. PubMed ID: 20153897
[TBL] [Abstract][Full Text] [Related]
16. Thiopurine S-methyltransferase polymorphisms: efficient screening method for patients considering taking thiopurine drugs.
Wusk B; Kullak-Ublick GA; Rammert C; von Eckardstein A; Fried M; Rentsch KM
Eur J Clin Pharmacol; 2004 Mar; 60(1):5-10. PubMed ID: 14985890
[TBL] [Abstract][Full Text] [Related]
17. Should TPMT genotype and activity be used to monitor 6-mercaptopurine treatment in children with acute lymphoblastic leukaemia?
Fakhoury M; Andreu-Gallien J; Mahr A; Medard Y; Azougagh S; Vilmer E; Jacqz-Aigrain E
J Clin Pharm Ther; 2007 Dec; 32(6):633-9. PubMed ID: 18021342
[TBL] [Abstract][Full Text] [Related]
18. Interference free and simplyfied liquid chromatography-based determination of thiopurine S-methyltransferase activity in erythrocytes.
Khalil MN; Erb N; Khalil PN; Escherich G; Janka-Schaub GE
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Jul; 821(1):105-11. PubMed ID: 15897017
[TBL] [Abstract][Full Text] [Related]
19. [Thiopurine S-methyltransferase gene sequence analysis of ALL children severely intolerant to 6-mercaptopurine].
Ma XL; Li WJ; Zheng J; Wang B; Jin M; Zhang DW; Li ZG; Zhang YX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Aug; 20(4):876-9. PubMed ID: 22931646
[TBL] [Abstract][Full Text] [Related]
20. Role of TPMT and ITPA variants in mercaptopurine disposition.
Gerbek T; Ebbesen M; Nersting J; Frandsen TL; Appell ML; Schmiegelow K
Cancer Chemother Pharmacol; 2018 Mar; 81(3):579-586. PubMed ID: 29387964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
